Revvity Surprises with Q2 Sales Beat, Raises Full-Year Guidance

Revvity (NYSE:RVTY) has reported Q2 CY2025 sales of $720.3 million, a 4.1% YoY increase and a 1.1% beat on analyst estimates. The company's non-GAAP profit of $1.18 per share was 3.4% above analysts' consensus estimates. Revvity has slightly lifted its revenue guidance for the full year to $2.86 billion and lowered its full-year adjusted EPS guidance to $4.90.

Revvity Inc. (NYSE: RVTY) has announced its financial results for the second quarter of 2025, showcasing robust performance with revenue of $720.3 million, a 4.1% year-on-year (YoY) increase, and a 1.1% beat on analyst estimates [2]. The company's non-GAAP profit per share of $1.18 was 3.4% above analysts' consensus estimates, highlighting strong operational efficiency.

Revvity's revenue growth was driven by a 4% organic growth, which excludes one-time events and currency fluctuations. The company's adjusted operating income for the quarter was $192 million, with an adjusted operating profit margin of 26.6%, indicating strong profitability [2].

In the Life Sciences segment, revenue increased 5% YoY, while the Diagnostics segment saw a 3% YoY increase. Both segments contributed to the overall revenue growth, with the Life Sciences segment reporting an adjusted operating income of $115 million and the Diagnostics segment reporting $89 million [2].

Looking ahead, Revvity has slightly adjusted its full-year revenue guidance to $2.86 billion and lowered its full-year adjusted EPS guidance to $4.90. The adjustments reflect recent changes in foreign currency exchange rates and the company's expectation of 2% to 4% organic growth for the year [2].

The company's president and CEO, Prahlad Singh, stated, "The power of Revvity's transformation and consistent execution were evident in our second-quarter performance, enabling us to exceed expectations despite the evolving market environment. With a strong pipeline of innovation, high-performing teams, and disciplined operational focus, we're well-positioned to deliver long-term value creation for our shareholders" [2].

Revvity will discuss its second-quarter results and outlook during a webcast on July 28, 2025, at 8:00 a.m. Eastern Time [2].

References:
[1] https://finviz.com/news/113539/labcorp-nyse-lh-posts-better-than-expected-sales-in-q2
[2] https://www.morningstar.com/news/business-wire/20250728970540/revvity-announces-financial-results-for-the-second-quarter-of-2025